Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baibei Yifei Capsules (Baibei Yifei Jiaonang) is a traditional Chinese herbal medicine developed and manufactured by Yunnan Yongzitang Pharmaceutical, a subsidiary of Hunan Hansen Pharmaceutical. The formulation consists of ten herbal ingredients: Stemona root (Baibu), lily bulb (Baihe), Fritillaria thunbergii (Zhebeimo), Platycodon (Jiegeng), Aster (Ziwan), Mahonia (Gonglaomu), Bletilla (Baiji), pumice (Haifushi), Panax notoginseng (Sanqi), and licorice (Gancao). It is indicated for the treatment of chronic bronchitis and cough associated with lung yin deficiency. According to Traditional Chinese Medicine (TCM) principles, the capsule functions to nourish yin, moisten the lungs, suppress coughing, and resolve phlegm. It is an approved commercial product in China (Approval No. Z20025124).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baibei Yifei Capsules.